Highly efficient site-specific transgenesis in cancer cell lines.

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• Transgenes are crucial for identifying cancer-related genes.
• Random transgene integration causes variable expression, hindering research.
• A site-specific insertion system is needed to overcome this limitation.

Purpose of the Study:

• To characterize the utility of the PhiC31 integrase-mediated site-specific insertion system (PhiC31-IMSI) for transgene introduction into cancer cells.
• To establish a reliable method for consistent transgene expression in cancer cell line engineering.

Main Methods:

• A docking site was inserted into human cancer cell lines, and single-copy clones were selected.
• The PhiC31 integrase was used to insert genes of interest specifically into the docking site.
• Reporter genes and inducible systems were employed to assess transgene expression and control.

Main Results:

• PhiC31-IMSI demonstrated reproducible and reliable transgene insertion in Pc-3 and SKOV-3 cancer cell lines.
• Isogenic clones exhibited comparable reporter gene expression levels from the same integration locus.
• Genetically modified cell lines retained parental properties in vivo, and temporal control of transgene expression was achieved.
• The system supports high-throughput cloning and live imaging applications.

Conclusions:

• The PhiC31-IMSI system offers a powerful and reliable tool for cancer gene characterization.
• This method facilitates the study of cancer-related genes by ensuring consistent transgene expression.
• The system's adaptability supports various applications in cancer research and drug development.